Exploring Metabolic and Immunological Biomarkers for Oral Squamous Cell Carcinoma: Potential Targets for Precision Therapy
Biology · 22.08.2025 · 14 (9) · 1109
DOI: 10.3390/biology14091109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 22.08.2025. Verfasst von Rajneesh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Banaras Hindu University, Varanasi, Institute of Eminence Grant of Banaras Hindu University (BHU-IoE), Office of Director, Institute of Medical Sciences, Banaras Hindu University.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) is a malignant neoplasm of the oral epithelium that constitutes majority of oral cancers and is strongly associated with risk factors such as tobacco use and genetic alterations. Mortality rates for OSCC are high because many cases are misdiagnosed or identified at later stages, and treatment options are limited with high recurrence. Therefore, there is an urgent need for improved diagnostic and therapeutic strategies. OSCC tumor cells, like those in other solid malignancies, exhibit significant alterations in metabolic pathways and the immune microenvironment. These changes can serve as valuable biomarkers for early detection and as targets for innovative treatment strategies. This review summarizes the current understanding of metabolic and immunological biomarkers that are either currently in use for OSCC or are in different phases of clinical trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.
- Department of Human Genetics, Guru Nanak Dev University, Amritsar 143005, India.
- Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.
- Oral & Maxillofacial Surgery Unit, Faculty of Dental Sciences, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.
- Department of Genetics, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA.
ORCID-Profile: Vibhav Gautam, Rajiv Pathak, Akhilesh Kumar Singh
Förderung
- Banaras Hindu University, Varanasi
- Institute of Eminence Grant of Banaras Hindu University (BHU-IoE)
- Office of Director, Institute of Medical Sciences, Banaras Hindu University
Zitieren
APA
Rajneesh, Tiwari, R., Singh, V. K., Kumar, A., Mehrotra, S., Gautam, V., Neville, J. F., Bansal, V., Pathak, R., Singh, A. K., & Kumar, R. (2025). Exploring Metabolic and Immunological Biomarkers for Oral Squamous Cell Carcinoma: Potential Targets for Precision Therapy. Biology, 14(9), 1109. https://doi.org/10.3390/biology14091109
Vancouver
Rajneesh, Tiwari R, Singh VK, Kumar A, Mehrotra S, Gautam V, et al. Exploring Metabolic and Immunological Biomarkers for Oral Squamous Cell Carcinoma: Potential Targets for Precision Therapy. Biology. 2025;14(9):1109. doi:10.3390/biology14091109
BibTeX
@article{Rajneesh2025,
author = {Rajneesh and Tiwari, Rahul and Singh, Vishal Kumar and Kumar, Awnish and Mehrotra, Sanjana and Gautam, Vibhav and Neville, J F and Bansal, Vyomika and Pathak, Rajiv and Singh, Akhilesh Kumar and Kumar, Rajiv},
title = {Exploring Metabolic and Immunological Biomarkers for Oral Squamous Cell Carcinoma: Potential Targets for Precision Therapy},
journal = {Biology},
year = {2025},
volume = {14},
number = {9},
pages = {1109},
doi = {10.3390/biology14091109}
}
EUVIMED